Luke Smith represents companies across the nation in complex litigation and antitrust compliance. He provides antitrust counseling and analysis in proposed mergers and acquisitions, including Hart-Scott Rodino Act (HSR) pre-merger filing notifications. Other clients, primarily healthcare companies, have benefited from Luke’s knowledge of industry-specific antitrust issues, including clinical integration, accountable care organizations, payor/provider negotiations, and healthcare joint ventures. During the past five years, Luke has advised on transactions worth more than $12 billion, two thirds of which were in the healthcare industry.
American Bar Association, Antitrust Section
American Health Lawyers Association (AHLA)
Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019. Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.
Represented C-III Capital Partners in its sale of California-based tech company Real Capital Markets (RCM) to LightBox
Represented Tivity Health, Inc. in its acquisition of Nutrisystem, Inc.
Represented Genesco in its sale of Lids its hat-focused division
Represented Western Dental Services, a portfolio company of New Mountain Capital, in its acquisition of Guardian Life Insurance Company’s Dental Service Organization
Represented American Physician Partners in its acquisition of Texas-based Emergigroup Physician Associates
Represented Hibbett Sports (Nasdaq: HIBB) in Acquisition of City Gear
Represented Wright Medical Group in its acquisition of Cartiva, Inc.
Represented Envision Healthcare in its definitive agreement to sell to KKR for $9.9 billion
Vanderbilt Law Review